SMTL ID : 7mlk.1

Crystal structure of human PI3Ka (p110a subunit) with MMV085400 bound to the active site determined at 2.9 angstroms resolution

Coordinates

PDB Format

Method

X-RAY DIFFRACTION 2.91 Å

Oligo State

monomer

Ligands

1 x ZHY: 4-[6-(3,4,5-trimethoxyanilino)pyrazin-2-yl]benzamide(Non-covalent)

ZHY.1: 17 residues within 4Å: Chain A: R.690, S.694, W.700, I.720, K.722, D.730, Y.756, I.768, E.769, V.770, V.771, S.774, T.776, Q.779, M.842, I.852, D.853 13 PLIP interactions: 13 interactions with chain A Hydrophobic interactions: A:W.700, A:Y.756, A:I.768, A:I.852, A:I.852, A:I.852 Hydrogen bonds: A:R.690, A:S.694, A:D.730, A:Y.756, A:V.771, A:Q.779, A:D.853

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Krake, S.H. et al., Discovery of 2,6-disubstituted pyrazines as potent PI4K inhibitors with antimalarial activity. To Be Published

Release Date

2022-05-04

Peptides

Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform: A

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform